A 32-year-old man with a known giant cell tumor of the distal femur is being evaluated for surgical planning. Plain radiographs and MRI have been completed. Which additional investigation is most appropriate to assess for malignant transformation and determine the aggressiveness of the lesion?

## Assessing Aggressiveness and Malignant Potential in GCT ### Histological Markers of Aggressiveness **Key Point:** Immunohistochemistry (IHC) for **p53** and **Ki-67** on the biopsy specimen is the most appropriate investigation to assess the aggressiveness of GCT and predict risk of malignant transformation. **High-Yield:** GCT is classified into three grades based on histological features: - **Grade 1 (benign):** Low cellularity, few mitoses, low Ki-67 index (<5%) - **Grade 2 (intermediate):** Moderate cellularity, occasional mitoses, intermediate Ki-67 (5–10%) - **Grade 3 (aggressive):** High cellularity, numerous mitoses, high Ki-67 (>10%), p53 overexpression ### Immunohistochemical Markers in GCT | Marker | Expression in Benign GCT | Expression in Aggressive/Malignant GCT | Clinical Significance | |---|---|---|---| | **Ki-67** | <5% | >10% | Proliferation index; predicts recurrence and malignant potential | | **p53** | Negative/weak | Positive/strong | Tumor suppressor; overexpression indicates aggressive behavior | | **Cyclin D1** | Low | High | Cell cycle progression; associated with aggressive phenotype | | **RANKL** | Present in stromal cells | Increased expression | Promotes osteoclastogenesis; may correlate with aggressiveness | **Clinical Pearl:** Approximately **2–5% of GCTs undergo malignant transformation** to sarcoma (fibrosarcoma, osteosarcoma, or giant cell sarcoma), usually after recurrence or radiation therapy. High Ki-67 (>10%) and p53 overexpression are independent predictors of: - Local recurrence - Metastatic potential - Malignant transformation ### Role of IHC in Treatment Planning ```mermaid flowchart TD A[Confirmed GCT on biopsy]:::outcome --> B[Perform IHC for Ki-67<br/>and p53]:::action B --> C{Ki-67 <5% and<br/>p53 negative?}:::decision C -->|Yes| D[Grade 1: Benign<br/>Low recurrence risk]:::outcome C -->|No| E{Ki-67 5-10% or<br/>p53 weak positive?}:::decision E -->|Yes| F[Grade 2: Intermediate<br/>Moderate recurrence risk]:::outcome E -->|No| G[Grade 3: Aggressive<br/>High recurrence/malignant risk]:::outcome D --> H[Curettage + adjuvant<br/>therapy may suffice]:::action F --> I[Curettage + adjuvant<br/>therapy recommended]:::action G --> J[Wide excision or<br/>amputation considered]:::action ``` **Mnemonic:** **AGGRESSIVE GCT** = **A**ggressive histology, **G**rade 3, **G**reat Ki-67 (>10%), **R**ecurrence risk high, **E**arly malignant transformation, **S**trong p53, **S**urgical margin control critical, **I**mmunohistochemistry essential, **V**ital for prognosis, **E**xcision planning **Warning:** Do not confuse histological grading with radiographic aggressiveness. A radiographically aggressive lesion (wide zone of transition, cortical breakthrough) may still be Grade 1 on histology. Conversely, a radiographically benign lesion may show Grade 3 histology with high malignant potential.